<?xml version="1.0" encoding="UTF-8" ?><rss 
        version         = "2.0"
        xmlns:content   = "http://purl.org/rss/1.0/modules/content/"
        xmlns:wfw       = "http://wellformedweb.org/CommentAPI/"
        xmlns:dc        = "http://purl.org/dc/elements/1.1/"
        xmlns:atom      = "http://www.w3.org/2005/Atom"
        xmlns:sy        = "http://purl.org/rss/1.0/modules/syndication/"
        xmlns:slash     = "http://purl.org/rss/1.0/modules/slash/"
        type            = "0"
                >
        <channel><item post_id='46880'><title>Innatoss Laboratories startet Test zum Nachweis von neutralisierenden Antikörpern mit dem cPass(TM) Kit von GenScript gegen SARS-CoV-2 in Europa</title><link>https://business24.ch/2020/09/18/innatoss-laboratories-startet-test-zum-nachweis-von-neutralisierenden-antikoerpern-mit-dem-cpasstm-kit-von-genscript-gegen-sars-cov-2-in-europa/</link><pubDate>Fri, 18 Sep 2020 15:00:02 +0000</pubDate>		<category><![CDATA[Presseportal]]></category>
		<category><![CDATA[Presseportal-Archiv]]></category>
		<category><![CDATA[noinjection]]></category>
<guid isPermalink='false'>https://business24.ch/?p=46880</guid><post-id xmlns="com-wordpress:feed-additions:1">46880</post-id></item></channel>
      </rss>